Skip to main content

Flunisolide nasal Pregnancy and Breastfeeding Warnings

Brand names: Nasalide, Nasarel

Medically reviewed by Drugs.com. Last updated on Aug 28, 2024.

Flunisolide nasal Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: Not assigned

Animal studies showed teratogenicity and fetotoxicity at oral doses 2 and 4 times the maximum recommended daily intranasal dose for adults. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Flunisolide nasal Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Other corticosteroids are excreted in human milk.

See references

See also

References for pregnancy information

  1. (2018) "Product Information. Flunisolide (flunisolide nasal)." Bausch and Lomb Americas, Inc.

References for breastfeeding information

  1. (2018) "Product Information. Flunisolide (flunisolide nasal)." Bausch and Lomb Americas, Inc.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer